The Platelet Transfusion in Cerebral Hemorrhage (PATCH) trial, a trial of platelet transfusion in patients on antiplatelet agents with cerebral hemorrhage, suggested that platelets worsened outcomes. Reanalysis of the data… Click to show full abstract
The Platelet Transfusion in Cerebral Hemorrhage (PATCH) trial, a trial of platelet transfusion in patients on antiplatelet agents with cerebral hemorrhage, suggested that platelets worsened outcomes. Reanalysis of the data by the investigators revealed that despite randomization, some, if not all, of the adverse effects of platelets reflected worse baseline hemorrhage in patients in the platelet arm.
               
Click one of the above tabs to view related content.